Wellnex Life Ltd Cash Flow Conversion Efficiency

Latest as of June 2025: 0.154x

Wellnex Life Ltd cash flow conversion efficiency. Based on the latest financial reports, Wellnex Life Ltd (WNX) has a cash flow conversion efficiency ratio of 0.154x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$1.73 Million ≈ $1.22 Million USD) by net assets (AU$11.25 Million ≈ $7.96 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Wellnex Life Ltd (2013–2024)

Cash flow conversion efficiency of Wellnex Life Ltd from 2013 to 2024. This chart illustrates how Wellnex Life Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View WNX live share price for real-time trading data and today's change.

Wellnex Life Ltd Cash Flow Conversion Ratio Explained

Wellnex Life Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Wellnex Life Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Wellnex Life Ltd ranked by their cash flow conversion efficiency. Also see market cap of Wellnex Life Ltd for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
CCH Holdings Ltd Ordinary Shares
NASDAQ:CCHH
N/A
Mobico Group Plc
LSE:MCG
-1.446x
Modus Therapeutics Holding AB
ST:MODTX
-0.552x
Noram Lithium Corp
V:NRM
-0.023x
Churchill Resources Inc
V:CRI
-0.401x
Hydrotek Public Company Limited
BK:HYDRO
-0.054x
Icon Energy Ltd
AU:ICN
0.072x
GRANITE CREEK COPPER
F:GRK
N/A

Annual Cash Flow Conversion Efficiency for Wellnex Life Ltd (2013–2024)

The table below shows the annual cash flow conversion efficiency of Wellnex Life Ltd from 2013 to 2024. Review WNX FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 AU$11.25 Million
≈ $7.96 Million
AU$-666.00K
≈ $-471.24K
-0.059x +94.74%
2023-12-31 AU$6.06 Million
≈ $4.29 Million
AU$-6.82 Million
≈ $-4.82 Million
-1.125x +89.20%
2022-12-31 AU$594.00K
≈ $420.29K
AU$-6.19 Million
≈ $-4.38 Million
-10.419x -427.43%
2021-12-31 AU$4.36 Million
≈ $3.08 Million
AU$-8.61 Million
≈ $-6.09 Million
-1.975x -111.24%
2020-12-31 AU$-249.00K
≈ $-176.18K
AU$-4.38 Million
≈ $-3.10 Million
17.574x +754.92%
2019-12-31 AU$2.82 Million
≈ $2.00 Million
AU$-7.57 Million
≈ $-5.36 Million
-2.683x -989.09%
2018-12-31 AU$51.44 Million
≈ $36.40 Million
AU$-12.67 Million
≈ $-8.97 Million
-0.246x -150.25%
2017-12-31 AU$61.54 Million
≈ $43.54 Million
AU$-6.06 Million
≈ $-4.29 Million
-0.098x +81.46%
2016-12-31 AU$6.98 Million
≈ $4.94 Million
AU$-3.71 Million
≈ $-2.62 Million
-0.531x -704.96%
2015-12-31 AU$9.71 Million
≈ $6.87 Million
AU$-640.63K
≈ $-453.29K
-0.066x -154.49%
2014-12-31 AU$-1.06 Million
≈ $-747.62K
AU$-127.91K
≈ $-90.50K
0.121x +144.23%
2013-12-31 AU$-740.32K
≈ $-523.82K
AU$202.64K
≈ $143.38K
-0.274x --

About Wellnex Life Ltd

AU:WNX Australia Packaged Foods
Market Cap
$3.27 Million
AU$4.62 Million AUD
Market Cap Rank
#29315 Global
#1617 in Australia
Share Price
AU$0.07
Change (1 day)
+0.00%
52-Week Range
AU$0.04 - AU$0.19
All Time High
AU$97.62
About

Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia, New Zealand, and the United Kingdom. The company offers topical anti-inflammatory creams, sprays, and roll-ons under the Pain Away brand; caffeine energy liquid capsules and multivitamins under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth w… Read more